Morgan Stanley cuts price target for ASX 200

This expert reckons ASX investors might not see too much upside in 2025.

ASX 200 investors are arguably facing a level of uncertainty not seen in years right now.

Rewind a few months to the start of 2025, and investors were on a high. Excitement over the incoming Trump administration's supposedly pro-growth policies, falling global inflation, and robust growth had left investors feeling confident about the future. What a difference a few months can make.

Today, uncertainty is arguably the prevalent feeling in the markets. Although the Trump tariffs have been paused for 90 days, their potential impact on the global economy is still bothering investors. As is the chances of an American recession, not to mention the possible loss of the independence of the US Federal Reserve.

Meanwhile, US government bond yields are rising, the US dollar is losing ground, and gold continues to set new records.

In these conditions, it is challenging to make predictions about what the S&P/ASX 200 Index (ASX: XJO) might do next.

Far from the rosy optimism that we saw at the start of 2025, the ASX 200 is now nursing a hefty 5.1% loss for the year to date (at current pricing).

Unfortunately for ASX investors, there's little room for improvement either, at least according to one expert.

As reported in the Australian Financial Review (AFR) this week, investment bank Morgan Stanley has just cut its outlook for the Australian share market.

Woman looking at a phone with stock market bars in the background.

Image source: Getty Images

Morgan Stanley: ASX 200 to hit 8,000 points by 2026

Until this week, Morgan Stanley had been pencilling in an ASX 200 at 8,500 points by year's end, just a whisker away from the index's all-time high of 8,615.2 points that we saw in February.

However, the investment bank has just slashed that target to 8,000 points. As the ASX 200 is sitting at 7,790 points at present, this implies that the index will rise by just 2.7% over the rest of 2025.

Interestingly, Morgan Stanley estimates that investors will adjust the earnings multiple that the broader market trades at, thanks to increased risk in the global economy. It now expects the ASX 200 will reach a price-to-earnings (P/E) ratio of 16.2 going forward, down from 17.

In a note to clients, Morgan Stanley equity strategist Chris Nicol stated that while Australia had "levers to weather the storm in a relative sense, meaningful upside seems capped" going forward.

He added, "We acknowledge the likelihood that equities will continue to experience a level of de-rating in the multiple paid for earnings".

Given the volatility the ASX 200 has endured this year, many investors might be relieved if the index manages to rise another 2.7% by the end of 2025. But we'll have to wait and see if Morgan Stanley is on the money here.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

A woman weraing a stripy t-shirt winks as she points to the decorative gold crown on her head.
ASX Share Market News

CBA shares back on top of the ASX 200 as BHP dives 13% this week

CBA shares have rallied 9.5% over the past month whilst BHP tumbled 13% this week.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

2 ASX shares tipped to grow up to 122% in the next 12 months

These companies could be on the cusp of something big.

Read more »